| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Astria Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 26,550 | 11 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATXS | Astria Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 12 Jun 2025, 19:13 |
| ATXS | Astria Therapeutics, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 06 Jun 2024, 16:06 |
| ATXS | Astria Therapeutics, Inc. | 02 Jun 2023 | 1 | $0 | 4 | Director | 06 Jun 2023, 08:06 |
| ATXS | Astria Therapeutics, Inc. | 09 Jun 2022 | 1 | $0 | 4/A | Director | 21 Jun 2022, 08:33 |
| ATXS | CATABASIS PHARMACEUTICALS INC | 02 Jun 2021 | 1 | $0 | 4 | Director | 02 Jun 2021, 19:16 |